4//SEC Filing
GLASSMAN DANIEL 4
Accession 0000864268-04-000012
CIK 0000864268other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 3:12 PM ET
Size
20.4 KB
Accession
0000864268-04-000012
Insider Transaction Report
Form 4
GLASSMAN DANIEL
DirectorChairman, Pres. & CEO10% Owner
Transactions
- Discretionary Transaction
Common Stock
2004-01-13$24.40/sh+17$415→ 10,835 total(indirect: By 401(k))
Holdings
- 25,000
Stock Options (Right to buy)
Exercise: $2.17From: 2001-02-23Exp: 2006-02-22→ Common Stock (25,000 underlying) - 16,005(indirect: By Banyan Communications Group, Inc.)
Class B Common Stock
- 11,500(indirect: By IRA)
Common Stock
- 18,000
Stock Options (Right to buy)
Exercise: $1.41From: 2003-09-12Exp: 2005-09-11→ Common Stock (18,000 underlying) - 309,361
Class B Common Stock
- 8,460(indirect: By DLD Partners)
Common Stock
- 31,279
Stock Options (Right to buy)
Exercise: $8.81From: 2003-07-09Exp: 2004-07-08→ Common Stock (31,279 underlying) - 341,589
Stock Options (Right to buy)
Exercise: $1.44From: 2000-12-05Exp: 2005-12-04→ Common Stock (341,589 underlying) - 57,370(indirect: By Spouse)
Class B Common Stock
- 150,000
Stock Options (Right to buy)
Exercise: $1.17From: 2002-10-26Exp: 2004-10-25→ Common Stock (150,000 underlying) - 267,811
Common Stock
- 16,000(indirect: By Foundation)
Common Stock
- 9,733(indirect: By Partnership)
Class B Common Stock
- 13,880(indirect: By Spouse)
Common Stock
- 315,000
Stock Options (Right to buy)
Exercise: $13.13From: 2005-03-22Exp: 2007-03-21→ Common Stock (315,000 underlying) - 2,977(indirect: By 401(k))
Common Stock
- 12,554
Stock Options (Right to buy)
Exercise: $10.58From: 2003-07-09Exp: 2006-07-08→ Common Stock (12,554 underlying)
Documents
Issuer
BRADLEY PHARMACEUTICALS INC
CIK 0000864268
Entity typeother
Related Parties
1- filerCIK 0000902023
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 3:12 PM ET
- Size
- 20.4 KB